Search alternatives:
associated decrease » associated increase (Expand Search), associated disease (Expand Search), associated diseases (Expand Search)
teer decrease » greater decrease (Expand Search)
associated decrease » associated increase (Expand Search), associated disease (Expand Search), associated diseases (Expand Search)
teer decrease » greater decrease (Expand Search)
-
1
-
2
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…The values are expressed as the means ± SDs and were analyzed according to the variance of the factorial design. **, *** and ****denote <i>p</i> < 0.01, < 0.001 and < 0.0001, respectively; ns = not significant.…”
-
3
-
4
-
5
-
6
CKO mice display decreased skin barrier function and perturbed homeostasis.
Published 2025Subjects: -
7
Comparison of questionnaire scores among genotypes for the significant associations.
Published 2025Subjects: -
8
-
9
-
10
-
11
-
12
-
13
-
14
ECoG timescales decrease during spatial attention.
Published 2025“…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”
-
15
-
16
-
17
-
18
-
19
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”
-
20